Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Langer

Showing results (131-140 of 218) with videos related to

Pageof 22
Sort By:
Journal of Proteome Research|September 4, 2010
Proteomic analysis of PAXgene-fixed tissuesBilge Ergin, Stephan Meding, Rupert Langer, et al.
Annals of the New York Academy of Sciences|June 1, 2018
Risk factors for esophageal cancer: emphasis on infectious agentsHala El-Zimaity, Vincenzo Di Pilato, Maria Novella Ringressi, et al.
Biochemical and Biophysical Research Communications|July 6, 2021
Increased LAMP2A levels correlate with a shorter disease-free survival of HER2 negative breast cancer patients and increased breast cancer cell viabilityIgor Tokarchuk, Félice A Janser, Anna M Schläfli, et al.
British Journal of Cancer|March 25, 2023
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trialsAvani Athauda, Matthew Nankivell, Rupert Langer, et al.
Oncotarget|September 13, 2014
Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapyMichaela Aichler, Martin Motschmann, Uta Jütting, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012
Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institutionDaniel Reim, Martin Loos, Fabian Vogl, et al.
Oxidative Medicine and Cellular Longevity|October 8, 2020
Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the LungTereza Losmanová, Félice A Janser, Magali Humbert, et al.
Virchows Archiv : an International Journal of Pathology|August 31, 2023
Minimally invasive autopsies for the investigation of pulmonary pathology of COVID-19-experiences of a longitudinal series of 92 patientsPetar Noack, Claudia Grosse, Jacob Bodingbauer, et al.
Oxidative Medicine and Cellular Longevity|December 10, 2021
Corrigendum to "Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung"Tereza Losmanová, Félice A Janser, Magali Humbert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinomaRupert Langer, Katja Specht, Karen Becker, et al.
Pageof 22

Showing results (131-140 of 218) with videos related to

Sort By:
Pageof 22
Journal of Proteome Research|September 4, 2010
Proteomic analysis of PAXgene-fixed tissuesBilge Ergin, Stephan Meding, Rupert Langer, et al.
Annals of the New York Academy of Sciences|June 1, 2018
Risk factors for esophageal cancer: emphasis on infectious agentsHala El-Zimaity, Vincenzo Di Pilato, Maria Novella Ringressi, et al.
Biochemical and Biophysical Research Communications|July 6, 2021
Increased LAMP2A levels correlate with a shorter disease-free survival of HER2 negative breast cancer patients and increased breast cancer cell viabilityIgor Tokarchuk, Félice A Janser, Anna M Schläfli, et al.
British Journal of Cancer|March 25, 2023
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trialsAvani Athauda, Matthew Nankivell, Rupert Langer, et al.
Oncotarget|September 13, 2014
Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapyMichaela Aichler, Martin Motschmann, Uta Jütting, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012
Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institutionDaniel Reim, Martin Loos, Fabian Vogl, et al.
Oxidative Medicine and Cellular Longevity|October 8, 2020
Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the LungTereza Losmanová, Félice A Janser, Magali Humbert, et al.
Virchows Archiv : an International Journal of Pathology|August 31, 2023
Minimally invasive autopsies for the investigation of pulmonary pathology of COVID-19-experiences of a longitudinal series of 92 patientsPetar Noack, Claudia Grosse, Jacob Bodingbauer, et al.
Oxidative Medicine and Cellular Longevity|December 10, 2021
Corrigendum to "Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung"Tereza Losmanová, Félice A Janser, Magali Humbert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinomaRupert Langer, Katja Specht, Karen Becker, et al.
Pageof 22